PIAS
NVO

PCA Investment Advisory Services’s Novo Nordisk NVO Stock Holding History

PCA Investment Advisory Services’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,422
Closed -$208K – 110
2024
Q4 		$208K Buy
2,422
+90
+4% +$9.73K 0.1% 136
2024
Q3 		$278K Buy
2,332
+2
+0.1% +$267 0.13% 108
2024
Q2 		$333K Buy
2,330
+302
+15% +$40K 0.17% 81
2024
Q1 		$260K Sell
2,028
-1
-0% -$119 0.15% 97
2023
Q4 		$210K Buy
+2,029
New +$201K 0.14% 111
2023
Q3 		– Sell
-1,728
Closed -$140K – 318
2023
Q2 		$140K Buy
+1,728
New +$141K 0.08% 157

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

PCA Investment Advisory Services's NVO Position: Q1 2025 in Review

PCA Investment Advisory Services sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,422 shares — an estimated $208K sold.

PCA Investment Advisory Services first reported a position in NVO in Q2 2023 and held it in 6 quarters. The position peaked at $333K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • PCA Investment Advisory Services reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • PCA Investment Advisory Services sold 2,422 Novo Nordisk shares in Q1 2025, an estimated $208K.
  • PCA Investment Advisory Services first reported a position in Novo Nordisk in Q2 2023 and held it in 6 quarters.
  • PCA Investment Advisory Services's Novo Nordisk position peaked at $333K in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on PCA Investment Advisory Services's 13F filing for Q1 2025, filed 5 May 2025.